125 related articles for article (PubMed ID: 38568191)
21. Combination blockade of KLRG1 and PD-1 promotes immune control of local and disseminated cancers.
Tata A; Dodard G; Fugère C; Leget C; Ors M; Rossi B; Vivier E; Brossay L
Oncoimmunology; 2021 Jun; 10(1):1933808. PubMed ID: 34188973
[TBL] [Abstract][Full Text] [Related]
22. Molecular basis for E-cadherin recognition by killer cell lectin-like receptor G1 (KLRG1).
Nakamura S; Kuroki K; Ohki I; Sasaki K; Kajikawa M; Maruyama T; Ito M; Kameda Y; Ikura M; Yamamoto K; Matsumoto N; Maenaka K
J Biol Chem; 2009 Oct; 284(40):27327-35. PubMed ID: 19654330
[TBL] [Abstract][Full Text] [Related]
23. Expression of CD94-NKG2A inhibitory receptor is restricted to a subset of CD8+ T cells.
Braud VM; Aldemir H; Breart B; Ferlin WG
Trends Immunol; 2003 Apr; 24(4):162-4. PubMed ID: 12697440
[TBL] [Abstract][Full Text] [Related]
24. An atypical KLRG1 in Nile tilapia involves in adaptive immunity as a potential marker for activated T lymphocytes.
Zhang Y; Li K; Li C; Liang W; Li K; Li J; Wei X; Yang J
Fish Shellfish Immunol; 2021 Jun; 113():51-60. PubMed ID: 33798718
[TBL] [Abstract][Full Text] [Related]
25. Expression of inhibitory "killer cell lectin-like receptor G1" identifies unique subpopulations of effector and memory CD8 T cells.
Beyersdorf NB; Ding X; Karp K; Hanke T
Eur J Immunol; 2001 Dec; 31(12):3443-52. PubMed ID: 11745363
[TBL] [Abstract][Full Text] [Related]
26. Efficient generation of a monoclonal antibody against the human C-type lectin receptor DCIR by targeting murine dendritic cells.
Heidkamp GF; Neubert K; Haertel E; Nimmerjahn F; Nussenzweig MC; Dudziak D
Immunol Lett; 2010 Aug; 132(1-2):69-78. PubMed ID: 20566350
[TBL] [Abstract][Full Text] [Related]
27. Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction.
Spaggiari GM; Contini P; Dondero A; Carosio R; Puppo F; Indiveri F; Zocchi MR; Poggi A
Blood; 2002 Dec; 100(12):4098-107. PubMed ID: 12393468
[TBL] [Abstract][Full Text] [Related]
28. The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor.
Borrego F; Masilamani M; Kabat J; Sanni TB; Coligan JE
Mol Immunol; 2005 Feb; 42(4):485-8. PubMed ID: 15607803
[TBL] [Abstract][Full Text] [Related]
29. Expression of IL-7Rα and KLRG1 defines functionally distinct CD8
Remmerswaal EBM; Hombrink P; Nota B; Pircher H; Ten Berge IJM; van Lier RAW; van Aalderen MC
Eur J Immunol; 2019 May; 49(5):694-708. PubMed ID: 30883723
[TBL] [Abstract][Full Text] [Related]
30. KLRG1-expressing CD8+ T cells are exhausted and polyfunctional in patients with chronic hepatitis B.
Wang L; Liao F; Yang L; Jiang L; Duan L; Wang B; Mu D; Chen J; Huang Y; Hu Q; Chen W
PLoS One; 2024; 19(5):e0303945. PubMed ID: 38776335
[TBL] [Abstract][Full Text] [Related]
31. Targeting androgen signaling in ILC2s protects from IL-33-driven lung inflammation, independently of KLRG1.
Blanquart E; Mandonnet A; Mars M; Cenac C; Anesi N; Mercier P; Audouard C; Roga S; Serrano de Almeida G; Bevan CL; Girard JP; Pelletier L; Laffont S; Guéry JC
J Allergy Clin Immunol; 2022 Jan; 149(1):237-251.e12. PubMed ID: 33964300
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of the NK cell receptor KLRG1 by virus-specific CD8 T cells during persistent antigen stimulation.
Thimme R; Appay V; Koschella M; Panther E; Roth E; Hislop AD; Rickinson AB; Rowland-Jones SL; Blum HE; Pircher H
J Virol; 2005 Sep; 79(18):12112-6. PubMed ID: 16140789
[TBL] [Abstract][Full Text] [Related]
33. Amelioration of acute graft-versus-host disease by NKG2A engagement on donor T cells.
Kawamura H; Yagita H; Nisizawa T; Izumi N; Miyaji C; Vance RE; Raulet DH; Okumura K; Abo T
Eur J Immunol; 2005 Aug; 35(8):2358-66. PubMed ID: 15997467
[TBL] [Abstract][Full Text] [Related]
34. A protocol for the production of KLRG1 tetramer.
Terrizzi SC; Banh C; Brossay L
J Vis Exp; 2010 Jan; (35):. PubMed ID: 20068548
[TBL] [Abstract][Full Text] [Related]
35. Highly differentiated cytotoxic T cells in inclusion body myositis.
Greenberg SA; Pinkus JL; Kong SW; Baecher-Allan C; Amato AA; Dorfman DM
Brain; 2019 Sep; 142(9):2590-2604. PubMed ID: 31326977
[TBL] [Abstract][Full Text] [Related]
36. Cross-priming CD8+ T cells by targeting antigens to human dendritic cells through DCIR.
Klechevsky E; Flamar AL; Cao Y; Blanck JP; Liu M; O'Bar A; Agouna-Deciat O; Klucar P; Thompson-Snipes L; Zurawski S; Reiter Y; Palucka AK; Zurawski G; Banchereau J
Blood; 2010 Sep; 116(10):1685-97. PubMed ID: 20530286
[TBL] [Abstract][Full Text] [Related]
37. Expression and Clinical Significance of KLRG1 and 2B4 on T Cells in the Peripheral Blood and Tumour of Patients with Cervical Cancer.
Guo Y; Feng Y; Fan P; Yao X; Peng Y; Wang R; Kuerban G
Immunol Invest; 2022 Apr; 51(3):670-687. PubMed ID: 33401997
[TBL] [Abstract][Full Text] [Related]
38. NK cell expression of the killer cell lectin-like receptor G1 (KLRG1), the mouse homolog of MAFA, is modulated by MHC class I molecules.
Corral L; Hanke T; Vance RE; Cado D; Raulet DH
Eur J Immunol; 2000 Mar; 30(3):920-30. PubMed ID: 10741410
[TBL] [Abstract][Full Text] [Related]
39. Functional characterization of a conserved pair of NKR-P1 receptors expressed by NK cells and T lymphocytes in liver and gut.
Kveberg L; Sudworth A; Todros-Dawda I; Inngjerdingen M; Vaage JT
Eur J Immunol; 2015 Feb; 45(2):501-12. PubMed ID: 25382546
[TBL] [Abstract][Full Text] [Related]
40. Targeting C-type lectin-like molecule-1 for antibody-mediated immunotherapy in acute myeloid leukemia.
Zhao X; Singh S; Pardoux C; Zhao J; Hsi ED; Abo A; Korver W
Haematologica; 2010 Jan; 95(1):71-8. PubMed ID: 19648166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
